Tolerability and Immunogenicity of a Single 40-µg Dose of Recombinant Botulinum Vaccine A/B (rBV A/B) for the Production of BabyBIG in Volunteers With Existing Botulinum Immunity
Phase of Trial: Phase II
Latest Information Update: 04 Jan 2019
At a glance
- Drugs Botulism vaccine
- Indications Botulism
- Focus Pharmacodynamics
- 27 Dec 2018 Planned primary completion date changed from 1 Sep 2019 to 1 Oct 2019.
- 27 Dec 2018 Status changed from not yet recruiting to recruiting.
- 26 Sep 2018 New trial record